The State Department issued a waiver for lifesaving aid, but HIV clinics remain shut and uncertainty lingers over the future of PEPFAR, which has saved 25 million lives.

Uganda sought to dispel fears among HIV patients that a US aid freeze will interrupt treatment and promised that such programs will continue.

The Trump administration has moved to stop the supply of lifesaving drugs for HIV, malaria, and tuberculosis in countries supported by USAID around the globe.

A map of deadly infectious diseases known to attack the central nervous system (CNS) of people who are already suffering with HIV has unearthed diagnosis "blank spots" in Africa, according to research published today in The Lancet Global Health.

A stop in all of PEPFAR’s work shuttered clinics this week. Then, a new exemption for “life-saving” treatment left organizations uncertain.

The World Health Organization (WHO) expresses deep concern on the implications of the immediate funding pause for HIV programmes in low- and middle-income countries.

The latest waiver appeared to give the go-ahead for funding for medication under PEPFAR, a major US programme against HIV/AIDS.

Major barriers in screening for fatty liver disease in patients with HIV included uncertainties about testing, diagnostic data insufficiency, low priority, time constraints, and referral limitations.

State of the Union Address, President George W. Bush described to Congress a dire situation as HIV/AIDS continued to ravage communities around the globe. The year before had been one of the deadliest years of the epidemic: Globally,

The extent of the impacts of the Trump administration’s sudden 90-day freeze of almost all foreign aid is still unclear almost a week on, as officials and aid workers overseas try to make sense of which activities must be suspended.

Marco Rubio, US Secretary of State, has authorised an “Emergency Humanitarian Waiver” that ensures continued access to HIV treatment.